Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis Ha Young YoonMin Hyoung AhnHye Sun Gwak Review 08 May 2020 Pages: 1053 - 1058
A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients Caitlin Phillips-ChavezMichael WatsonJanet Schloss Review 22 May 2020 Pages: 1059 - 1074
Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose Jeroen RoosendaalStefanie L. GroenlandNeeltje Steeghs Clinical Trial Open access 19 May 2020 Pages: 1075 - 1082
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials Cinzia Dello RussoNatalia CappoliPierluigi Navarra Clinical Trial 24 May 2020 Pages: 1083 - 1092
Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool Rafael Dal-Ré Clinical Trial 24 May 2020 Pages: 1093 - 1102
Dexmedetomidine for prevention of propofol injection pain upon induction of anesthesia: a meta-analysis Liting JiWeihua SunXiaofeng Xu Pharmacodynamics 08 May 2020 Pages: 1103 - 1110
Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysis Shinya SuzukiTakeshi Yamashitaon behalf of J-ELD AF investigators Pharmacodynamics 25 May 2020 Pages: 1111 - 1124
Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects Jiaming LiXiaoqian WangDi Zhao Pharmacogenetics 08 May 2020 Pages: 1125 - 1133
A drug–drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers Mai ShibataJunko ToyoshimaTetsuya Nishimura Pharmacokinetics and Disposition Open access 16 May 2020 Pages: 1135 - 1141
Prediction of the exposure to a 400-mg daily dose of efavirenz in pregnancy: is this dose adequate in extensive metabolisers of CYP2B6? Manoranjenni ChettyMichael P. DanckwertsAndrea Julsing Pharmacokinetics and Disposition 07 May 2020 Pages: 1143 - 1150
Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use Helena RamströmSiv MartiniMarie-Louise Ovesjö Pharmacoepidemiology and Prescription Open access 09 May 2020 Pages: 1151 - 1160
Effectiveness of beta blockers in patients with and without a history of myocardial infarction Sanjay VermaEdward L. PetersonDavid E. Lanfear Pharmacoepidemiology and Prescription 22 May 2020 Pages: 1161 - 1168
Paradoxical adverse drug reactions: descriptive analysis of French reports Yan HakimiNadine PetitpainHaleh Bagheri Pharmacoepidemiology and Prescription 16 May 2020 Pages: 1169 - 1174
Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain—differences between regional pharmacovigilance centres and pharmaceutical industry C. Fernandez-FernandezE. Lázaro-BengoaD. Montero Corominas Pharmacoepidemiology and Prescription 23 May 2020 Pages: 1175 - 1181
Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study Ji Min HanHye Won HanHye Sun Gwak Pharmacoepidemiology and Prescription 22 May 2020 Pages: 1183 - 1191
Simultaneous paracetamol may promote ibuprofen-induced closure of ductus arteriosus Outi AikioSanna JuujärviMikko Hallman Letter to the Editor 20 May 2020 Pages: 1193 - 1195
Direct acting oral anticoagulants and alopecia: to go further with data mining in pharmacovigilance databases Basile ChrétienMarion SassierSophie Fedrizzi Letter to the Editor 20 May 2020 Pages: 1197 - 1198